Newsbenzinga
TG Therapeutics Starts Phase 2 Clinical Study Of BRIUMVI In Adult Participants With Treatment-Resistant Schizophrenia
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…